Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trialJames Spicer, Sophia N. Karagiannis, Rebecca Kristeleit et al.|Nature Communications|2023Cited by 35
A multi-modular phase I/II study of UCB6114, a first-in-class, fully human IgG4P anti-Gremlin-1 monoclonal antibody, as monotherapy and in combination with mFOLFOX6 or trifluridine/tipiracil, for patients with advanced gastrointestinal (GI) tumors.Debashis Sarker, Sophie Glatt, Udai Banerji et al.|Journal of Clinical Oncology|2022Cited by 2